I nfluenza vaccination of health care workers in the United States is estimated to be below 40%, despite the availability of vaccines with demonstrated safety and efficacy and the continued recommendations for· health care workers to be vaccinated (Simeonsson, Summers-Bean, & Connolly, 2004) . Employees who decline vaccination may be at increased risk of contracting influenza, which could result in lost work time. Because they may be occupationally exposed to influenza, health care workers are among the subgroupsin the general populationadvised to accept influenza vaccine. However, health care workers sometimesrefuse the vaccinebecause of perceivedadverse effects, including illness from the influenza vaccine itself (Nichol & Hague, 1997) . In one study, absenteeism was attributed to vaccine-related adverse effects by 11 of 83 workers (13%), resulting in .46 workdays lost per dose administered (Stephenson, Roper, & Nicholson, 2002) .
Influenza viruses are a leading cause of excess morbidity and mortality both in the United States and worldwide (McCullers, 2005) . Pneumonia and influenza together are ranked as the seventh leading cause of death in the United States (American Lung Association, 2004) . Influenza symptoms include fever, headache, extreme tiredness, dry cough, sore throat, runny or stuffy nose, and muscle aches (Centers for Disease Control and Prevention [CDC), 2004) . Influenza has a rapid onset and the acute illness lasts on average 3 days (Therapeutics Initiative, 2000) . Influenza A is more common and more severe (Therapeutics Initiative, 2000) . During the 2004 to 2005 influenza season, influenza A (Hl), A (H3N2), and B viruses co-circulated worldwide, with a predominance of influenzaA (H3N2) (CDC, 2005) . In the United States, influenza activity occurred at low levels from October to mid-December, increased at a steady rate during January, and peaked in mid-February. Influenza A (H3N2) viruses were predominant (CDC, 2005) .
During influenza season (October to March), individuals who accept the influenza vaccine may experience mild side effects, including influenza-like symptoms, but are protected against the more serious consequences of a full-scale influenza infection. Hospital occupational health departments strongly encourage their health care workers to receive influenza vaccine to avoid the direct effects of outbreaks in health care settings and the indirect effects of disruption of normal operations of health care institutions, shortages of health care workers, fewer elective admissions, and income loss because of absenteeism (Simeonsson et al., 2004) .
In this study, to evaluate if health care workers receiving influenza vaccine experience more symptoms than those health care workers not receiving vaccine, health care workers were surveyed from Inova Loudoun Hospital in Leesburg, VA. The completed questionnaires were analyzed by absenteeism, symptoms reported, and resulting health care resources used. Results of this study were used by the occupational health department to further encourage health care workers who might otherwise have declined to receive influenza vaccine. The results were also used to determine if the hospital's current standard procedure for administering the majority of influenza vaccine during a 2 to 3 week period is appropriate, or if this time frame should be expanded, given a difference in symptoms and resulting absenteeism between those who receive and do not receive influenza vaccine.
METHODOLOGY

Sample Population
The population for this study was a convenience sample drawn from more than 1,500 hospital employees, volunteers, physicians, and students at a ISS-bed community hospital. An optimal sample size of 390 was determined based on a calculation of significantly detectable differences (95% confidence interval and 80% power) in symptom response among the vaccinated group and the unvaccinated group. Because of the convenience sample, only 341 individuals were successfully engaged as participants in this study.
The hospital's department of occupational health strongly encourages its employees, physicians, volunteers, and students [all herein referred to as employees] to receive influenza vaccine annually, offered to them at no charge. Approximately half of the hospital employees were expected to receive the vaccine for the 2004 to 2005 influenza season. This estimate was based on employees in the past refusing the vaccine for one or more of the following reasons-the employee does not get sick; the employee is afraid they will "catch the flu" from the influenza vaccine; or the employee refuses all vaccines.
A total of 613 of more than 1,500 employees including 527 employees, 31 physicians, 40 volunteers, 7 agency staff, 7 students, and 1 "other" received the influenza vaccine (432 = Fluzone" [Aventis Pasteur Inc., Swiftwater, PAl; 181 = FluMist™ [MedImmune Vaccines Inc., Gaithersburg, MD]) between November 2004 and March of 2005, through the hospital occupational health department. All were asked to complete 478 and return the questionnaires. A total of 341 completed questionnaires were received-a response rate of 56% for the vaccinated group.
Survey Methods
Prior to initiation of the study, the Institutional Review Board (IRB) determined the study was exempt from IRB oversight using 45 CRF 46 as a model.
At the time of influenza vaccination, employees receiving vaccine were provided a diary-like questionnaire and asked to complete it for a period of 7 days following vaccination. The questionnaires were provided to the employees by the occupational health department representative administering the vaccine. The questionnaire included age, gender, type of vaccine received, date, if they had specific symptoms (e.g., fever, headache, extreme tiredness, dry cough, sore throat, runny nose, stuffy nose, muscle aches), the number of days absent because of such symptoms, and if they had influenza vaccines in the past with or . without symptoms If employees answered yes to having symptom(s), they were also asked to specify if prescription or non-prescription medications were taken, and if a health care provider was seen because of the symptom(s).
Employees not receiving influenza vaccine were asked to complete the questionnaire, answering the same questions for a 7-day period during the study period, November 2004 to February 2005. This unvaccinated group was identified and asked to participate through administrative communications and director initiatives. This step involved announcements at hospital administrative and staff meetings during which employees who did not receive vaccine by the hospital or other health care provider were asked to complete the control group questionnaire, which has the same questions as the vaccination group questionnaire. Hospital management distributed the questionnaires to the unvaccinated employees when they confirmed with the employee that they had not received vaccine. In this manner, a total of 77 surveys were completed by employees not receiving influenza vaccine, producing a response rate of approximately 50%. Completed anonymous surveys were returned to the occupational health department.
RESULTS
Between November 2004 and February 2005, a total of 341 study questionnaires were completed (264 in the influenza vaccine group [Fluzone intramuscular injection =201 or 76%; FluMist intranasal spray =63 or 24%]; and 77 in the unvaccinated group).
After paper-based questionnaires were completed by employees, an analytical data set was created from actual responses. Microsoft Office Excel 2003 (Redmond, WA) was used for data entry. To ensure reliability and accuracy of actual employee responses in the database, a 100% verification of the data was completed. SAS software, version 9.1 of the SAS System for Windows (SAS Institute Inc., Cary, NC), was used to construct tables and statistical testing across three groups, those receiving Fluzone and FluMist, and those not receiving vaccine. "Differences in proportions" to measuredifferences in symptoms reported based on vaccine status were calculated. 
Researchers also calculated mean differences in absenteeism associated with symptoms reported. The distribution of returned questionnaires by vaccination group and time frame is reported in Table I . According to county health department statistics, the influenza season peaked February 28, 2005 in the community the hospital serves, with 160 cases of influenza-like illness (ILl) reported ( Figure) . The following CDC case definition for ILl was used for purposes of health care provider reporting to the county health department-fever greater than or equal to 100°F (37.8°C) and cough or sore throat or both, in the absence of a known cause (e.g., streptococcus).
The unvaccinated group reported a higher rate of all symptoms (i.e., fever, headache, extreme tiredness, dry cough, sore throat, runny nose, stuffy nose, muscle aches) when compared to the vaccinated group combining both Fluzone and FluMist groups ( Table 2) . Of these symptoms, all were considered statistically significant (p < .05) except for fever and sore throat. However, when the vaccinated group was analyzed by Fluzone, FluMist, and unvaccinated group, the FluMist had significantly higher (p < .05) symptom rates for dry cough, runny nose, and stuffy nose ( Table 2 ). The unvaccinated group had significantly higher (p < .05) symptom rates for fever, headache, extreme tiredness, and sore throat. The unvaccinated group also had higher symptom rates for muscle aches; however, this was not considered statistically significant. The Fluzone group experienced significantly fewer (p < .05) symptoms compared to the unvaccinated group for headache, extreme tiredness, dry cough, sore throat, runny nose, and stuffy nose. The FluMist group was not statistically different from the unvaccinated group with respect to all symptoms reported.
Sixty-one employees (30.2%) in the Fluzone group, 36 (58.1%) in the FluMist group, and 34 (44.1%) in the unvaccinated group reported more than one symptom. More than one symptom resulting in more than I day absent was reported by 3.4% of the vaccinated group (Fluzone 3.5%; FluMist 3.2%) and 13% (chi-square = 10.4, p~.006) of the unvaccinated group.
Of those receiving Fluzone, 93.5% reported receiving influenza vaccine on average 6.4 times prior, and experiencing influenza-like symptoms 11.9% of those times. In the FluMist group, 88.9% reported receiving influenza vaccine on average 4.6 times prior and experiencing influenza-like symptoms 17% of those times. 
DISCUSSION
In the past several years, the hospital in this study has made a concerted effort to encourage as many hospital employees as possible to receive the influenza vaccine to prevent potentially serious illness, transmission of that illness to coworkers and clients, and absenteeism because of illness. Shortages of vaccine in the past have been challenging, but none as challenging as during the 2004 to 2005 influenza season. The hospital's lower employee vaccination rate was 41% (613 of 1,500 employees), down from 48% (724 of 1,500 employees) for the 2003 to 2004 influenza season.
The hospital typically begins administering influenza vaccine in mid-October or when the CDC recommends it. However, in September 2004, Chiron Corporation (Emeryville, CAl, manufacturer of Fluvirin", announced a delay in the arrival of the vaccine because some lots of vaccine did not meet sterility standards at its English manufacturing center. Chiron and Aventis Pasteur Inc. were each expected to produce approximately 50 million doses of their influenza vaccines, and MedImmune Inc. was to supply approximately 1.5 million doses of its intranasal spray vaccine, FluMist™. As a result of the shortage, the hospital was delayed in receiving the I,000 doses of the Fluvirin it had ordered from Chiron, and was thereby forced to delay administration of vaccine until November. Also because of the shortage, the hospital was forced to prioritize the order in which employees would receive the limited vaccine quantities. Initially, the influenza vaccine (FluMist and Fluzone) was offered to personnel in intensive care units, emergency departments, respiratory care, and long-term care, following the restrictions specified for vaccines by the state health department. The remaining vaccine supply was offered to employees working in medical and surgical units, birthing center and nurseries, security and environmental services, and then all remaining departments.
The influenza intramuscular injection, or flu shot, (inactivated virus) is preferred over live, intranasal vaccine for physicians, nurses, or anyone in close contact with immuno-compromised individuals. However, for the 2004 to 2005 influenza season, the state health department lifted restrictions for administering intranasal vaccine to health care workers, except for those included in other established contraindications and those caring for anyone with a severely weakened immune system (e.g., individuals who have had an organ or bone marrow transplant, individuals in reverse isolation). Because it is associated with shedding via droplet nuclei, RuMist is typically not provided to hospital employees. However,because of the initial shortage, the hospital provided RuMist in addition to Fluzone, to maximize vaccination of employees. RuMist would not have been administered at all if the delay had not occurred, resulting in the hospital not receiving the supply of Fluvirin that had been ordered.
III
Influenza vaccine administration would have been targeted for the majority of employees during a 2-to 3week time period at the onset of administration in November. The employees who requested influenza vaccination initially in November would not have been turned away had it not been for the shortage. The shortage directly affected the number of employees being vaccinated in a timely fashion, resulting in influenza vaccinations being administered during a 4-month period. Further, the total number vaccinated was 7% lower in the 2004 to 2005 influenza season than in the 2003 to 2004 season.
The chief limitation of this study arises from selection bias. Employees were allowed to selectively opt for use or nonuse of the influenza vaccine based on factors not directly observed in this study. For example, those opting for vaccination might be more "at risk" because of prior infection, co-morbidity, exposure to clients, or some combination of these. A second limitation of this study is the difference in follow-up procedures between the vaccinated group (i.e., completion in the 7 days following vac-cination) and the unvaccinated (i.e., a self-selected time period of 7 consecutive days during the 4-month study period). However, the majority (70%) of questionnaires used in this study were administered during the timeframe in which CDC reported peak frequency of influenza isolates, specifically between January 8 and March 5,2005. Therefore, the probability of influenza infection peaked during the study timeframe for all vaccine status groups.
It was not possible to control employees in either group to voluntarily complete and return surveys. In the unvaccinated group, employees could have chosen a 7day period when they were experiencing symptoms; however, this was not reported. Only 3% of the unvaccinated group questionnaires were completed in February, the month when the influenza season peaked. Finally, not all of the surveys in either group were returned, a potential response bias. Even with these limitations, this study was an attempt to measure symptom status among health care workers in a busy hospital setting, where study design controls are not always feasible or ethical.
The results of this study support the Occupational Health Department personnel continuing to encourage hospital employees to receive the influenza vaccine. However, the purchase of intranasal spray influenza vaccine for administration in subsequent influenza seasons is not planned. This is because of the greater number of absence days as shown in this study for the intranasal spray group. .0012 care provider
Continued on page 482. Influenza vaccine does notresult in higher rates of symptoms inthe 1 week post-vaccination period as compared to an unvaccinated group.
There is no greater employee absenteeism as a result ofthe influenza vaccine.
For those reporting absenteeism as a result of symptoms, mean absenteeism days was highest inthe Flu-Mist group (4.5 days) compared to the unvaccinated group (2.1 days) and the Fluzone group (1.9 days).
